NPB vs RMD · P/E 7.5, rev $380.2M vs P/E 29, rev $5.65B
Northpointe Bancshares, Inc. (NPB) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Northpointe Bancshares, Inc. (NPB) is a banks - regional company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported NPB revenue for 2025-12-31 was $380.2M. Net income was $83.4M. Revenue was up 19.7% from 2024-12-31 to 2025-12-31. NPB currently screens at market cap $582.7M and trailing P/E 7.5.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
NPB currently screens at market cap $582.7M and trailing P/E 7.5. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the NPB and RMD stock pages for the full models.
Not investment advice.